Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ESMO 2012 /
Chemotherapy and radiotherapy in advanced local non-small cell lung cancer

28th Sep - 2nd Oct 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 12.10.12
Views: 4554

Dr Dirk De Ruysscher – University of Leuven, Netherlands

Dr Dirk De Ruysscher talks to ecancer at ESMO 2012 in Vienna about the treatment of non-small cell lung cancer and current and previous clinical trial results.


The difficulty in choosing a treatment stems from the fact that not all patients react the same to combination chemotherapy and radiation treatment. While the majority of patients react better to concurrent radiotherapy, rather than sequential, there is a minority that does not.


Currently these topics are being investigated in on going trials.  Previous trials, such as the RTOG trial, showed an example of this when a high dose of chemotherapy is actually less effective than smaller doses. 


Filming supported by Amgen

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation